STVN Stevanato Group S.p.A. IFRS Annual reports only
Surgical & Medical Instruments & Apparatus · NYSE · SEC CIK 1849853 · Reporting currency EUR
Financial factors as of 2025-12-31 (FY2025), by fiscal year; growth vs the previous fiscal year
Growth
Margins
Returns
Leverage & solvency
Cash quality & payout
Factor history charts and full statement history on Pro 🔒
Financial statements
| Unit: EUR | FY20252025-12-31 | FY20242024-12-31 |
|---|---|---|
| Income statement | ||
| Revenue | 1.19B | 1.10B |
| Cost of revenue | 842.41M | 801.72M |
| Gross profit | 343.88M | 302.32M |
| R&D expense | 25.44M | 31.67M |
| SG&A expense | 99.66M | 93.75M |
| Operating income | 198.80M | 161.14M |
| Interest expense | 5.62M | 6.11M |
| Pretax income | 189.11M | 160.29M |
| Income tax | 49.27M | 42.52M |
| Net income | 139.84M | 117.78M |
| EPS (basic) | 0.51 | 0.43 |
| EPS (diluted) | 0.51 | 0.43 |
| Weighted avg. shares (diluted) | 272.96M | 271.15M |
| Balance sheet | ||
| Cash & equivalents | 130.60M | 98.27M |
| Receivables | 302.69M | 295.95M |
| Inventory | 268.25M | 245.22M |
| Current assets | 943.35M | 880.12M |
| PP&E, netmay include right-of-use assets (IFRS) | 1.39B | 1.25B |
| Goodwill | 49.98M | 49.98M |
| Intangibles | 36.87M | 33.59M |
| Total assets | 2.54B | 2.33B |
| Current liabilities | 535.88M | 477.47M |
| Total liabilities | 1.06B | 924.43M |
| Shareholders' equity | 1.49B | 1.40B |
| Cash flow statement | ||
| Operating cash flow | 286.08M | 155.78M |
| Capital expenditure | 263.76M | 302.60M |
| Free cash flow | 22.32M | -146.82M |
| Investing cash flow | -272.92M | -310.21M |
| Financing cash flow | 22.06M | 183.22M |
| Dividends paid | 14.74M | 14.46M |
Free plan shows the latest 2 periods; Pro shows all 7 🔒
· This company reports under IFRS: some line items differ from US GAAP — operating income is not required, interest expense may be broader "finance costs", and banks have no standard revenue line.
· This company files only annual reports with the SEC (20-F for foreign issuers), so there is no quarterly data; factors are by fiscal year and growth is vs the previous fiscal year.
· Amounts are in the company's reporting currency, EUR, not USD; the site does no currency conversion.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.